% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • opinionscincy opinionscincy Mar 22, 2012 11:10 AM Flag

    Read " 5 Billion Now Annual Sales/1# Cancer Drug" link

    Breast cancer is one of the most common forms of cancer and is a disease with few options regarding treatment. Just look at Roche-Genetech's (RHHBY.PK); the company's drug Herceptin is one of the few advanced treatments for breast cancer patients, but only treats 25% of those diagnosed. NeuVax is believed to treat up to 75% (50% for sure) and with Herceptin returning $5 billion in annual sales, and only targeting 25% of patients, I think it is obvious why investors are so excited regarding the potential market for NeuVax.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.51+0.02(+1.34%)Nov 25 4:00 PMEST